These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18806690)

  • 1. Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats.
    Massie A; Schallier A; Mertens B; Vermoesen K; Bannai S; Sato H; Smolders I; Michotte Y
    Neuroreport; 2008 Oct; 19(16):1589-92. PubMed ID: 18806690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of the calcium binding protein calretinin in the rat striatum: effects of dopamine depletion and L-DOPA treatment.
    Mura A; Feldon J; Mintz M
    Exp Neurol; 2000 Aug; 164(2):322-32. PubMed ID: 10915571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nigrostriatal damage induced by 6-hydroxydopamine on the expression of glial cell line-derived neurotrophic factor in the striatum of the rat.
    Mertens B; Massie A; Michotte Y; Sarre S
    Neuroscience; 2009 Aug; 162(1):148-54. PubMed ID: 19383530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
    Yuan H; Sarre S; Ebinger G; Michotte Y
    J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic and bilateral changes in striatal VGLUT1 and 2 protein expression in hemi-Parkinson rats.
    Massie A; Schallier A; Vermoesen K; Arckens L; Michotte Y
    Neurochem Int; 2010 Sep; 57(2):111-8. PubMed ID: 20450947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.
    Decressac M; Mattsson B; Björklund A
    Exp Neurol; 2012 May; 235(1):306-15. PubMed ID: 22394547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic neurons of system x(c)⁻-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity.
    Massie A; Schallier A; Kim SW; Fernando R; Kobayashi S; Beck H; De Bundel D; Vermoesen K; Bannai S; Smolders I; Conrad M; Plesnila N; Sato H; Michotte Y
    FASEB J; 2011 Apr; 25(4):1359-69. PubMed ID: 21191088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats.
    Henze C; Earl C; Sautter J; Schmidt N; Themann C; Hartmann A; Oertel WH
    Brain Res; 2005 Aug; 1052(1):97-104. PubMed ID: 16005444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K; Finkelstein DI; Gundlach AL
    Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential astroglial activation in 6-hydroxydopamine models of Parkinson's disease.
    Henning J; Strauss U; Wree A; Gimsa J; Rolfs A; Benecke R; Gimsa U
    Neurosci Res; 2008 Dec; 62(4):246-53. PubMed ID: 18824050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats.
    Chung EK; Chen LW; Chan YS; Yung KK
    J Comp Neurol; 2008 Dec; 511(4):421-37. PubMed ID: 18831527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.
    Engler H; Doenlen R; Riether C; Engler A; Niemi MB; Besedovsky HO; del Rey A; Pacheco-López G; Feldon J; Schedlowski M
    Brain Behav Immun; 2009 May; 23(4):518-26. PubMed ID: 19486644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites.
    Heuer A; Smith GA; Lelos MJ; Lane EL; Dunnett SB
    Behav Brain Res; 2012 Mar; 228(1):30-43. PubMed ID: 22146593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats.
    Massie A; Goursaud S; Schallier A; Vermoesen K; Meshul CK; Hermans E; Michotte Y
    Neurochem Int; 2010 Nov; 57(5):572-8. PubMed ID: 20643175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
    Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK
    Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model.
    Warraich ST; Allbutt HN; Billing R; Radford J; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):85-90. PubMed ID: 18822357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model.
    Blandini F; Levandis G; Bazzini E; Nappi G; Armentero MT
    Eur J Neurosci; 2007 Jan; 25(2):397-405. PubMed ID: 17284180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lazaroid U-74389G on iron-induced reduction of striatal dopamine metabolism.
    Wesemann W; Solbach M; Nafe R; Grote C; Sontag KH; Riederer P; Jellinger K; Mennel HD; Clement HW
    J Neural Transm Suppl; 1995; 46():175-82. PubMed ID: 8821053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.